ICLR(ICON Public Limited Company) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $5.48B | $7.74B | $8.05B | $8.19B | $8.25B |
| 毛利润 | $1.51B | $2.21B | $2.33B | $2.34B | — |
| 营业利润 | $378.53M | $795.24M | $904.66M | $1.03B | $442.85M |
| 净利润 | $153.19M | $505.30M | $554.21M | $739.13M | $229.34M |
| 经营现金流 | $829.14M | $563.32M | $1.16B | $1.29B | $1.04B |
| 自由现金流 | $735.39M | $421.15M | $1.02B | $1.12B | $861.99M |
| 摊薄每股收益 | $2.25 | $6.13 | $6.70 | $8.90 | $2.90 |